Monocyte-derived CD1a+ and CD1a- dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation

被引:128
作者
Chang, CCJ [1 ]
Wright, A [1 ]
Punnonen, J [1 ]
机构
[1] Maxygen Inc, Redwood City, CA 94063 USA
关键词
D O I
10.4049/jimmunol.165.7.3584
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We describe a phenotypically and functionally novel monocyte-derived dendritic cell (DC) subset, designated mDC2, that lacks IL-12 synthesis, produces high levels of IL-10, and directs differentiation of Th0/Th2 cells. Like conventional monocyte-derived DC, designated mDC1, mDC2 expressed high levels of CD11c, CD40, CD80, CD86, and MHC class II molecules. However, in contrast to mDC1, mDC2 lacked expression of CD1a, suggesting an association between cytokine production profile and CD1a expression in DC. mDC2 could be matured into CD83(+) DC cells in the presence of anti-CD40 mAbs and LPS plus IFN-gamma but they remained CD1a(-) and lacked IL-12 production even upon maturation. The lack of IL-12 and CD1a expression by mDC2 did not affect their APC capacity, because mDC2 stimulated MLR to a similar degree as mDC1, However, while mDC1 strongly favored Th1 differentiation, mDC2 directed differentiation of Th0/Th2 cells when cocultured with purified human peripheral blood T cells, further indicating functional differences between mDC1 and mDC2, Interestingly, the transfection efficiency of mDC2 with plasmid DNA vectors was significantly higher than that of mDC1, and therefore mDC2 may provide improved means to manipulate Ag-specific T cell responses after transfection ex vivo. Taken together, these data indicate that peripheral blood monocytes have the capacity to differentiate into DC subsets with different cytokine production profiles, which is associated with altered capacity to direct Th cell differentiation.
引用
收藏
页码:3584 / 3591
页数:8
相关论文
共 68 条
  • [1] DNA vaccination: Transfection and activation of dendritic cells as key events for immunity
    Akbari, O
    Panjwani, N
    Garcia, S
    Tascon, R
    Lowrie, D
    Stockinger, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (01) : 169 - 177
  • [2] Role of interleukin 10 in specific immunotherapy
    Akdis, CA
    Blesken, T
    Akdis, M
    Wüthrich, B
    Blaser, K
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) : 98 - 106
  • [3] DENDRITIC CELLS GENERATED FROM PERIPHERAL-BLOOD TRANSFECTED WITH HUMAN TYROSINASE INDUCE SPECIFIC T-CELL ACTIVATION
    ALIJAGIC, S
    MOLLER, P
    ARTUC, M
    JURGOVSKY, K
    CZARNETZKI, BM
    SCHADENDORF, D
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) : 3100 - 3107
  • [4] Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
  • [5] 2-4
  • [6] CD47 ligation selectively downregulates human interleukin 12 production
    Armant, M
    Avice, MN
    Hermann, P
    Rubio, M
    Kiniwa, M
    Delespesse, G
    Sarfati, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (08) : 1175 - 1181
  • [7] Arthur JF, 1997, CANCER GENE THER, V4, P17
  • [8] Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors
    Ashley, DM
    Faiola, B
    Nair, S
    Hale, LP
    Bigner, DD
    Gilboa, E
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) : 1177 - 1182
  • [9] An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
    Asseman, C
    Mauze, S
    Leach, MW
    Coffman, RL
    Powrie, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) : 995 - 1003
  • [10] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252